Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment

Cheng Hu , Wenqi Liu , Jian Wang , Chen Hua , Linyu Long , Xia Yang , Lu Lu , Yun Zhu , Li Yang , Yunbing Wang , Xingdong Zhang

Collagen and Leather ›› 2025, Vol. 7 ›› Issue (1) : 38

PDF
Collagen and Leather ›› 2025, Vol. 7 ›› Issue (1) :38 DOI: 10.1186/s42825-025-00212-x
Research
research-article

Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment

Author information +
History +
PDF

Abstract

Heart failure or myocardial infarction (MI) is among the leading causes of death worldwide. However, current therapeutic procedures, including pharmacological interventions and ventricular assist devices, are unable to reverse the pathological changes and regenerate the injured cardiac tissue. Here, tailored recombinant humanized collagen type I (rhCol I) with high bioactivity for myocardial tissue-related cells was loaded into injectable hydrogels to construct a microenvironment favorable for angiogenesis, myocardial tissue repair and the restoration of heart function after MI. rhCol I-loaded hydrogels (gel@rhCol I) had a good response to the MI microenvironment, which indicated that they can release rhCol I for MI treatment. In vitro and in vivo results showed that the gel@rhCol I is able to effectively promote myocardial tissue repair and restore cardiac function after MI by inhibiting cell apoptosis, downregulating pro-inflammatory factors and promoting angiogenesis. In conclusion, injectable hydrogel based on tailored rhCol I exhibited great potential in the repair of damaged myocardial tissue. More importantly, the discovery of the mechanism of rhCol I promoting the repair of damaged myocardial tissue will broaden the clinical application of rhCol I for MI or heart failure treatment.

Graphic Abstract

Keywords

Myocardial infarction / Injectable hydrogel / Tailored recombinant humanized collagen type I / Myocardial tissue repair

Cite this article

Download citation ▾
Cheng Hu, Wenqi Liu, Jian Wang, Chen Hua, Linyu Long, Xia Yang, Lu Lu, Yun Zhu, Li Yang, Yunbing Wang, Xingdong Zhang. Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment. Collagen and Leather, 2025, 7(1): 38 DOI:10.1186/s42825-025-00212-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tariq U, Gupta M, Pathak S, Patil R, Dohare A, Misra SK. Role of biomaterials in cardiac repair and regeneration: therapeutic intervention for myocardial infarction. ACS Biomater Sci Eng, 2022, 8(8): 3271-3298

[2]

Leeson P, Lewandowski AJ. A new risk factor for early heart failure: preterm birth∗. J Am Coll Cardiol, 2017, 69(21): 2643-2645

[3]

Velagaleti RS, Vasan RS. Heart failure in the twenty-first century: Is it a coronary artery disease or hypertension problem?. Cardiol Clin, 2007, 25(4): 487-495

[4]

Zhang Z, Dalan R, Hu Z, Wang J-W, Chew NWS, Poh K-K, Tan R-S, Soong TW, Dai Y, Ye L, Chen X. Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease. Adv Mater, 2022, 34(35): 2202169

[5]

Wu P, Sai X, Li Z, Ye X, Jin L, Liu G, Li G, Yang P, Zhao M, Zhu S, Liu N, Zhu P. Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse. Bioact Mater, 2023, 20: 286-305

[6]

Zhang L, Li T, Yu Y, Shi K, Bei Z, Qian Y, Qian Z. An injectable conductive hydrogel restores electrical transmission at myocardial infarct site to preserve cardiac function and enhance repair. Bioact Mater, 2023, 20: 339-354

[7]

Wang Y, Li G, Yang L, Luo R, Guo G. Development of innovative biomaterials and devices for the treatment of cardiovascular diseases. Adv Mater, 2022, 34(462201971

[8]

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovas Res. 2022;cvac013.

[9]

Li Z, Hu S, Cheng K. Chemical engineering of cell therapy for heart diseases. Acc Chem Res, 2019, 52(61687-1696

[10]

Roger VL. Heart failure epidemic. Circulation, 2018, 138(1): 25-28

[11]

Wang Y. Research and progress of implantable cardiovascular materials and devices. Engineering, 2021, 7(12): 1707-1709

[12]

Wang S, Yao Y, Zhou T, Xie J, Ding J, Cao W, Shen L, Zhu Y, Gao C. Preservation of cardiac functions post myocardial infarction in vivo by a phenylboric acid-grafted hyaluronic hydrogel with anti-oxidation and accelerated degradation under oxidative microenvironment. Compos B Eng, 2022, 238: 109941

[13]

Pournemati B, Tabesh H, Jenabi A, Aghdam RM, Rezayan AH, Poorkhalil A, Tafti SHA, Mottaghy K. Injectable conductive nanocomposite hydrogels for cardiac tissue engineering: focusing on carbon and metal-based nanostructures. Eur Polymer J. 2022; 174:111336.

[14]

Hu C, Liu W, Long L, Wang Z, Zhang W, He S, Lu L, Fan H, Yang L, Wang Y. Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties. Biomaterials, 2022, 290: 121849

[15]

Zheng Z, Tan Y, Li Y, Liu Y, Yi G, Yu C-Y, Wei H. Biotherapeutic-loaded injectable hydrogels as a synergistic strategy to support myocardial repair after myocardial infarction. J Control Release, 2021, 335: 216-236

[16]

Wu T, Liu W. Functional hydrogels for the treatment of myocardial infarction. NPG Asia Mater, 2022, 14(1): 9

[17]

Cheng K, Malliaras K, Shen D, Tseliou E, Ionta V, Smith J, Galang G, Sun B, Houde C, Marbán E. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol, 2012, 59(3256-264

[18]

Hu S, Zhu D, Li Z, Cheng K. Detachable microneedle patches deliver mesenchymal stromal cell factor-loaded nanoparticles for cardiac repair. ACS Nano, 2022, 16(10): 15935-15945

[19]

Qian B, Yang Q, Wang M, Huang S, Jiang C, Shi H, Long Q, Zhou M, Zhao Q, Ye X. Encapsulation of lyophilized platelet-rich fibrin in alginate-hyaluronic acid hydrogel as a novel vascularized substitution for myocardial infarction. Bioact Mater, 2022, 7: 401-411

[20]

Zhang X, Sun Y, Yang R, Liu B, Liu Y, Yang J, Liu W. An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury. Biomaterials, 2022, 287: 121656

[21]

Li Y, Chen X, Jin R, Chen L, Dang M, Cao H, Dong Y, Cai B, Bai G, Gooding JJ, Liu S, Zou D, Zhang Z, Yang C. Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Sci Adv, 2021, 7(9): eabd6740

[22]

Si R, Gao C, Guo R, Lin C, Li J, Guo W. Human mesenchymal stem cells encapsulated-coacervated photoluminescent nanodots layered bioactive chitosan/collagen hydrogel matrices to indorse cardiac healing after acute myocardial infarction. J Photochem Photobiol B, 2020, 206: 111789

[23]

Kisling A, Lust RM, Katwa LC. What is the role of peptide fragments of collagen I and IV in health and disease?. Life Sci, 2019, 228: 30-34

[24]

Jiang X, Feng T, An B, Ren S, Meng J, Li K, Liu S, Wu H, Zhang H, Zhong C. A Bi-layer hydrogel cardiac patch made of recombinant functional proteins. Adv Mater, 2022, 34(192201411

[25]

Traverse JH, Henry TD, Dib N, Patel AN, Pepine C, Schaer GL, DeQuach JA, Kinsey AM, Chamberlin P, Christman KL. First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients. Basic Transl Sci, 2019, 4(6659-669

[26]

Ghovvati M, Kharaziha M, Ardehali R, Annabi N. Recent advances in designing electroconductive biomaterials for cardiac tissue engineering. Adv Healthcare Mater, 2022, 11(13): 2200055

[27]

Wang Y, Wang Z, Guo W, Bai L, Luo Q, Kwong Cheng C, Zhang W, Wu D, Hu C, Wang Y. An injectable extracellular matrix-mimicking conductive hydrogel for sequential treatment of ischemic stroke. Chem Eng J, 2024, 502: 158039

[28]

Horn MA, Trafford AW. Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling. J Mol Cell Cardiol, 2016, 93: 175-185

[29]

Zheng Z, Guo Z, Zhong F, Wang B, Liu L, Ma W, Yu C-Y, Wei H. A dual crosslinked hydrogel-mediated integrated peptides and BMSC therapy for myocardial regeneration. J Control Release, 2022, 347: 127-142

[30]

Hu C, Yang L, Wang Y. Recent advances in smart-responsive hydrogels for tissue repairing. MedComm Biomater Appl, 2022, 1(2e23

[31]

Chow HY, Zhang Y, Matheson E, Li X. Ligation Technologies for the Synthesis of Cyclic Peptides. Chem Rev, 2019, 119(179971-10001

[32]

Zou C, Duan X, Wu J. Enhanced extracellular production of recombinant Bacillus deramificans pullulanase in Escherichia coli through induction mode optimization and a glycine feeding strategy. Biores Technol, 2014, 172: 174-179

[33]

Liu W, Long L, Wang Z, He S, Han Y, Yang L, Hu C, Wang Y. A whole-course-repair system based on stimulus-responsive multifunctional hydrogels for myocardial tissue regeneration. Small Methods, 2024, 8(12): 2400121

[34]

Yang L, Wu H, Lu L, He Q, Xi B, Yu H, Luo R, Wang Y, Zhang X. A tailored extracellular matrix (ECM) - Mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen. Biomaterials, 2021, 276: 121055

[35]

Qin Y, Zhu Y, Lu L, Wu H, Hu J, Wang F, Zhang B, Wang J, Yang X, Luo R, Chen J, Jiang Q, Yang L, Wang Y, Zhang X. Tailored extracellular matrix-mimetic coating facilitates reendothelialization and tissue healing of cardiac occluders. Biomaterials, 2025, 313: 122769

[36]

Zhang B, Qin Y, Yang L, Wu Y, Chen N, Li M, Li Y, Wan H, Fu D, Luo R, Yuan L, Wang Y. A polyphenol-network-mediated coating modulates inflammation and vascular healing on vascular stents. ACS Nano, 2022, 16(46585-6597

[37]

Zhang W, Liu Y, Wang Z, He S, Liu W, Wu Y, Yang L, Hu C, Wang Y. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels. J Control Release, 2024, 369: 591-603

[38]

Leitinger B. Transmembrane collagen receptors. Annu Rev Cell Dev Biol, 2011, 27: 265-290

[39]

Kim JK, Xu Y, Xu X, Keene DR, Gurusiddappa S, Liang X, Wary KK, Höök M. A novel binding site in collagen type III for integrins α1β1 and α2β1. J Biol Chem, 2005, 280(3732512-32520

[40]

Farber P, Darmawan H, Sprules T, Mittermaier A. Analyzing protein folding cooperativity by differential scanning calorimetry and NMR spectroscopy. J Am Chem Soc, 2010, 132(17): 6214-6222

[41]

Li L, Zhang Q, Yuan X, Yang H, Qin S, Hong L, Pu L, Li L, Zhang P, Zhang J. Study of the molecular structure of proteins in fermented maize-soybean meal-based rations based on FTIR spectroscopy. Food Chem, 2024, 441: 138310

[42]

Yin Q, Zhu P, Liu W, Gao Z, Zhao L, Wang C, Li S, Zhu M, Zhang Q, Zhang X, Wang C. A conductive bioengineered cardiac patch for myocardial infarction treatment by improving tissue electrical integrity. Adv Healthc Mater. 2022;n/a(n/a):2201856.

[43]

Wang L, Jiang J, Hua W, Darabi A, Song X, Song C, Zhong W, Xing MMQ, Qiu X. Mussel-inspired conductive cryogel as cardiac tissue patch to repair myocardial infarction by migration of conductive nanoparticles. Adv Func Mater, 2016, 26(24): 4293-4305

[44]

Hsu M-N, Yu F-J, Chang Y-H, Huang K-L, Pham NN, Truong VA, Lin M-W, Kieu Nguyen NT, Hwang S-M, Hu Y-C. CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing. Biomaterials, 2020, 252: 120094

[45]

Wang N, Liu C, Wang X, He T, Li L, Liang X, Wang L, Song L, Wei Y, Wu Q, Gong C. Hyaluronic acid oligosaccharides improve myocardial function reconstruction and angiogenesis against myocardial infarction by regulation of macrophages. Theranostics, 2019, 9(71980-1992

[46]

Hu C, Long L, Cao J, Zhang S, Wang Y. Dual-crosslinked mussel-inspired smart hydrogels with enhanced antibacterial and angiogenic properties for chronic infected diabetic wound treatment via pH-responsive quick cargo release. Chem Eng J, 2021, 411: 128564

[47]

Wang L, Liu C, Li L, Wei H, Wei W, Zhou Q, Chen Y, Meng T-G, Jiao R, Wang Z-B, Sun Q-Y, Li W. RNF20 regulates oocyte meiotic spindle assembly by recruiting TPM3 to centromeres and spindle poles. Adv Sci, 2024, 11(132306986

[48]

Li W, Chen P, Pan Y, Lu L, Ning X, Liu J, Wei J, Chen M, Zhao P, Ou C. Construction of a Band-Aid Like Cardiac Patch for Myocardial Infarction with Controllable H2S Release. Adv Sci, 2022, 9(352204509

[49]

Liang S, Zhang Y, Wang H, Xu Z, Chen J, Bao R, Tan B, Cui Y, Fan G, Wang W, Wang W, Liu W. Paintable and rapidly bondable conductive hydrogels as therapeutic cardiac patches. Adv Mater, 2018, 30(231704235

[50]

Cuadrado I, Piedras MJGM, Herruzo I, Turpin MdC, Castejón B, Reventun P, Martin A, Saura M, Zamorano JL, Zaragoza C. EMMPRIN-targeted magnetic nanoparticles for in vivo visualization and regression of acute myocardial infarction. Theranostics. 2016;6(4):545-557.

[51]

Huang C, Zhou S, Chen C, Wang X, Ding R, Xu Y, Cheng Z, Ye Z, Sun L, Wang Z-J, Hu D, Jia X, Zhang G, Gao S. Biodegradable redox-responsive aiegen-based-covalent organic framework nanocarriers for long-term treatment of myocardial ischemia/reperfusion injury. Small, 2022, 18(472205062

[52]

Yu C, Yue Z, Shi M, Jiang L, Chen S, Yao M, Yu Q, Wu X, Zhang H, Yao F, Wang C, Sun H, Li J. An intrapericardial injectable hydrogel patch for mechanical-electrical coupling with infarcted myocardium. ACS Nano, 2022, 16(1016234-16248

[53]

Lu Y, Luo Y, Zhu R, Huang X, Bai S. Advanced bioactive hydrogels for the treatment of myocardial infarction. J Mater Chem B, 2022, 10(418375-8385

[54]

Luo Q, Gao Z, Bai L, Ye H, Ye H, Wang Y, Gao Y, Chen T, Chen H, Liu Y, Yang L, Hu C, Wu D, Wang Y. Bioactive peptide-based composite hydrogel for myocardial infarction treatment: ROS scavenging and angiogenesis regulation. Acta Biomater, 2025, 197: 167-183

[55]

Wu Y, Zhang W, Huang L, Xu X, He S, Wang Z, Liu W, Yao Y, Yang L, Hu C, Wang Y. Microenvironment-regulated hydrogels prepared with a brand-new small molecule cross-linker for stepwise treatment of myocardial infarction. Adv Healthcare Mater, 2025, 14(112500804

Funding

National Key Research and Development Programs(2022YFC2402800)

National Natural Science Foundation of China(32301115)

CAMS Innovation Fund for Medical Sciences (2021-I2M-5-013)

Fundamental Research Funds for the Central Universities(2023SCUH0011)

the Natural Science Foundation of Sichuan Province(2025ZNSFSC0245)

Med-X Innovation Programmer of Med-X Center of Materials, Sichuan University(MCMGD202303)

RIGHTS & PERMISSIONS

The Author(s)

AI Summary AI Mindmap
PDF

26

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/